Silence Therapeutics (SLN) Receivables Refunds (2018 - 2025)

Silence Therapeutics' Receivables Refunds history runs 8 years deep, the most recent figure standing at $2.6 million for Q4 2025.

• In Q4 2025, Receivables Refunds rose 69.29% year-over-year to $2.6 million; the TTM figure through Dec 2025 stood at $2.6 million (up 69.29% YoY), while the FY2025 annual figure was $2.6 million, up 69.29% from the prior year.
• Receivables Refunds came in at $2.6 million for Q4 2025 at Silence Therapeutics, up from $1.5 million in the prior quarter.
• In the past five years, Receivables Refunds ranged from a high of $2.0 billion in Q1 2021 to a low of $1.5 million in Q4 2024.
• A 5-year average of $123.9 million and a median of $5.1 million in 2023 frame the typical range for Receivables Refunds.
• On a YoY basis, Receivables Refunds climbed as much as 100.43% in 2021 and fell as far as 99.88% in 2021.
• Silence Therapeutics' Receivables Refunds stood at $9.4 million in 2021, then jumped by 86.32% to $17.5 million in 2022, then grew by 25.33% to $21.9 million in 2023, then sank by 92.96% to $1.5 million in 2024, then soared by 69.29% to $2.6 million in 2025.
• According to Business Quant data, Receivables Refunds over the past three periods registered $2.6 million, $1.5 million, and $8.5 million for Q4 2025, Q4 2024, and Q3 2024 respectively.

Peer Comparison